FMC
30
-11
UNP
48
-4
ROP
62
-3
HP
44
3
NTAP
62
-2
OI
49
6
KLAC
47
-3
KMX
61
3
MCHP
41
-4
EQIX
62
-3
ABBV
33
-24
MTCH
40
14
LRCX
49
-3
BAX
35
-3
NTRS
59
2
PWR
72
-2
APA
19
2
STT
67
3
KMB
28
-2
CMA
67
3
FMC
30
-11
UNP
48
-4
ROP
62
-3
HP
44
3
NTAP
62
-2
OI
49
6
KLAC
47
-3
KMX
61
3
MCHP
41
-4
EQIX
62
-3
ABBV
33
-24
MTCH
40
14
LRCX
49
-3
BAX
35
-3
NTRS
59
2
PWR
72
-2
APA
19
2
STT
67
3
KMB
28
-2
CMA
67
3
Financhill
Back

Vaxcyte Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
55

PCVX
Vaxcyte

Last Price:
99.30
Seasonality Move:
-3.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 41.2% based on the past 4 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $103.55. The Score for PCVX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • PCVX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 41.2% based on the past 4 years of stock performance.

Vaxcyte Stock Rating

Buy
55
Vaxcyte (PCVX) is a Buy

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCVX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
121.06
52-Week Low:
46.16

Prediction Charts

Market Cap:
12.91B
Price in USD:
103.55
Volume:
846.28K
Beta:
1.03

Technical Analysis

SMA50:
111.31
SMA100:
95.02
SMA200:
82.16
52-Wk Change:
115.1%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 103.55 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 111.82 112.14 113.02 111.16
Oct-24 112.45 112.32 114.02 111.16
Oct-25 113.00 112.94 114.50 112.19
Oct-28 114.40 112.80 115.56 112.69
Oct-29 112.35 105.56 112.91 102.84
Oct-30 104.14 106.13 107.67 103.07
Oct-31 105.30 106.35 108.72 104.36
Nov-1 106.76 107.29 109.30 105.65
Nov-4 105.73 106.49 108.06 103.72
Nov-5 105.18 107.56 108.40 104.06
Nov-6 114.58 104.05 115.94 102.01
Nov-7 104.08 102.70 106.98 101.87
Nov-8 103.21 106.67 107.31 103.17
Nov-11 106.67 103.55 107.22 102.83

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and a decrease next year of $0.85 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.